FDA Inspection
Daicel Chiral Technologies (India) Private LimitedDaicel Chiral Technologies (India) Private Limited – FDA Inspection, Nov 3, 2023
Record Details
This FDA Inspection record concerns Daicel Chiral Technologies (India) Private Limited, with an inspection on November 3, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 3, 2023
- Product Type
- Drugs
View Company Profile
ID · 88f3f986-87e9-4549-bcba-e7ddee5a1f1c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1237349
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Daicel Chiral Technologies (India) Private Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 14, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2023 | Not classified | Office of Inspections and Investigations | |
| March 26, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 10, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Daicel Chiral Technologies (India) Private Limited
- FDA Inspection 1229717 - 2024-02-14
- FDA Inspection 1200445 - 2023-02-08
- FDA Inspection 1089898 - 2019-03-26
- FDA Inspection 960646 - 2016-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.